Personalized Smoking Cessation Tool Based on Patient Lung CT Image

Overview

About this study

Imbio is developing a Smoking Cessation Report (Report) that includes data analysis from a CT lung cancer screening exam. This randomized controlled (RCT) trial will clinically validate the Report's effectiveness at motivating smokers to call a Quitline.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 30-pack year smoking history.
  • Currently smoke OR quit within the last 15 years and a category 1 or 2 Lung-RADS scan.

Exclusion Criteria: 

  • Current use of smoking cessation medications.
  • Scan read as a category 3, 4A, 4B or 4X in Lung-RADS.
  • Unstable medical or psychiatric conditions.
  • Current alcohol or drug use disorder.
  • Past-month suicidal ideation.
  • Past-year suicide attempt.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Burke, Ed.D.

Closed for enrollment

Contact information:

Nicotine Research Program

(800) 848-7853

nicotineresearch@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20437666

Mayo Clinic Footer